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Beneficial effect of thyroxin on recovery from toxic acute renal failure.
To determine the effect of thyroxin (T4) on the recovery from toxic
acute renal failure, rats were injected, subcutaneously, with K-dichro-
mate (15 mg/kg) and at the peak of the renal injury, each animal was
given either T4 (4 gIl00 g body weight, i.p.) or normal saline (NS). The
T4-treated rats had significantly better C1,, (669 35 1a1/min/lOO g body
weight), improved FENa (0.49 0.05%) and increased (835 50
mOsm/kg) as compared to animals given only NS (C1 422 27; FEN
1.02 0.12; and Uüm 613 23). A similar dose of T4 given to non-
injured control rats had no effect on renal function. The beneficial effect
of T4 on dichromate injected rats was sustained and lead to more
prompt recovery of glomerular function. To eliminate any hemodynam-
ic effects of T4, an isolated perfused kidney preparation was utilized,
and kidneys from dichromate injected rats treated with T4 had signifi-
cantly better C1,,, urine flow and FEN., compared to rats given NS.
Cellular morphology was better preserved in T4-treated animals. These
data indicate that treatment with T4 results in enhanced recovery from
an acute toxic renal insult and that this beneficial effect is unlikely to be
related to nonspecific systemic effects of the hormone.
Effet bénéfique de Ia thyroxine lors de Ia recuperation d'une insuffi.
sance renale aiguë toxique. Afin de determiner l'effet de Ia thyroxine (T4)
sur Ia récupération d'une insuffisance rénale aigue toxique, des rats ont
été injectés, par voie sous-cutanée, avec du K-dichromate (15 mglkg) et
au maximum de Ia lesion rénale, chaque animal a recu, par voie intra-
péritonéale, soit de Ia T4 (4 zg/I00 g poids) ou du solute physiologique
(NS). Les rats traitCs avec Ia T4 avaient une Ci,, significativement
nieilleure (669 35 1/min/l00 g poids), une FEN, améliorée (0,49
0,05%) et une U0,,, augmentée (835 50 mOsm/kg) par rapport aux
animaux ne recevant que NS (C1,, 422 27; FENa 1,02 0,12; et U0.,,,
613 23). Une dose identique de T4 donnée a des rats contrôles non
lésés n'avait pas d'effet sur Ia fonction rénale. L'effet benefique de T4
sur les rats injectés avec du dichromate était prolonge et aboutissait a
une rCcupération plus rapide de Ia fonction rénale. Afin d'éliminer des
effets hemodynamiques de T4, une preparation de rein isolé-perfusé a
etC utilisCe, et les reins provenant des rats injectés avec le dichromate et
traités avec T4 avaient une C1,,, un debit urinaire et une FEN. significa-
tivement meilleurs que les rats ayant recu le NS. La morphologie
cellulaire Ctait mieux prCservée chez les animaux traités avec T4. Ces
donnCes indiquent que le traitement par T4 entraine une récupération
plus rapide après une atteinte rénale aiguC toxique, et que cet effet
bCnCfique n'est sans doute pas reliC aux effets systémiques non specifi-
ques de l'hormone.
In 1977, Schulte-Wissermann, Straub, and Funke [1, 2]
studied effects on mercuric chloride-induced acute renal failure
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on enzymes in the renal tubule. These investigators noted that
rats treated with thyroxin had an accelerated reversal of the
defect in several enzymes including alkaline phosphatase and
Na-K ATPase. Moreover, Lo et al [3], Lo and Edelman [4],
Somjen, Ismail-Beigi, and Edelman [5] have shown that thyroid
hormone not only increases Na-K ATPase activity, but also
increases the number of Na-K ATPase units in the renal cortex.
This hormone is also known to augment protein synthesis and
stimulate glucose and amino acid uptake by epithelial cells [6,
7]. In addition, we have shown that the administration of ATP-
MgC12 will enhance recovery from several forms of acute renal
failure, and this salutary effect may be related to restoration of
Na-K ATPase and cell volume regulation I$—l21. Based on
these observations, we sought to determine the effect of thyrox-
in on the recovery from dichromate-induced toxic acute renal
failure,
Methods
All studies were performed on male Sprague-Dawley rats
weighing 210 to 250g. In experimental animals toxic acute renal
failure was induced by the subcutaneous injection of an aque-
ous solution of potassium dichromate (15 mg/cc) at a dose of 15
mg/kg body weight. Twenty-four hours after dichromate injec-
tion, the animals were treated with an intraperitoneal dose of
either thryoxin (T4, L-thyroxin, Sigma Chemical Co., St. Louis,
Missouri) or normal saline. Control animals were injected with
normal saline and then given either normal saline or T4 the next
day.
At the designated time interval, the animals were studied
using the following protocol. Each animal was anesthetized
(mactin 80 mg/kg, i.p.), and placed on a heated animal board to
maintain temperature between 36.5 and 37.5°C. A tracheostomy
was performed, and polyethylene catheters (PE-50) were se-
cured into the external jugular vein and bladder, After replace-
ment of surgical losses with isotonic saline (2 to 3% body
weight) a priming dose of 10 C of 3H-methoxy-inulin (New
England Nuclear Corp., Boston, Massachusetts) was given and
followed by a sustaining infusion of 10 ,aCi/hr in a volume of 1.2
ml. After a 45-mm equilibration period, inulin clearance (C1,,)
was determined by the average of three 10-mm urine collec-
tions. Blood samples were obtained from the tail at the midpoint
of each urine collection. The concentration of 3H-methoxy-
inulin was determined using a liquid scintillation counter, and
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Table 1. Effect of thyroxin on toxic acute renal failure°
d Saline, 0.1 cc, i.p.
P < 0.01 compared to saline-treated control group.
IP < 0.01 compared to saline-treated experimental group.
C1 was calculated using standard formulae [8]. Urinary osmo-
larity (Uosm) and fractional excretion of sodium (FENa) were
determined from specimens obtained during the clearance peri-
ods [8].
Specific studies
(I) To establish the time-course of reduction of glomerular
function after this toxic renal injury, we injected animals with
K-dichromate and C1. was determined 12, 16, 24 and 48 hr later.
At least five animals were studied at each time interval.
(2) To establish the initial effect of T4 on toxic acute renal
failure, we treated dichromate-injected animals at the height of
the renal injury (24 hr later), with either 0.1 cc of normal saline
(N = 12) or 4 g/l00 g body weight of T4 (N = 13). This amount
of T4 is twice the dosage required to produce normal serum
thyroxin levels in thyroidectomized rats [13]. Control animals
were given the same dose of normal saline (N = 10) or T4 (N
10). Both groups of animals were studied I day after treatment
which was 48 hr after the initial insult. Serum levels of total
thyroxin were determined at only one point in time, 24 hr after
treatment by the method of Seligson and Seligson [141.
(3) To evaluate the effect of various doses of T4, we injected
rats with dichromate and then treated them, 24 hr later, with T4
in a dose of none (N = 9). 2(N = 12), 4(N = 13), or 12(N = 8)
ig!l00 g body weight. C1,. was determined 24 hr after treatment.
(4) To determine whether the initial beneficial effect of T4
would be sustained, we treated dichromate-injected rats with
either 0.1 cc of normal saline or 12 ig/l00 g body weight ofT4
and studied either 2 days (N = 19) or four days (N = 18) after
the toxic renal injury.
(5) To eliminate any residual systemic or renal hemodynamic
effects of T4, an isolated perfused kidney preparation was
utilized: We injected rats with dichromate and then treated
them with either normal saline (N = 6) or 12 g/100 g body
weight of T4 (N = 6). Twenty-four hours after treatment, we
perfused the right kidney according to the technique described
by Nishiitsutsuji-Uwo, Ross, and Krebs [15], as modified by
Ross and Nizet [161. On the morning of study, rats were
anesthetized with phenobarbital, 30 mg/kg i.p. The peritoneal
cavity was then opened and a PE-lO polyethylene catheter was
inserted into the right ureter. One thousand units of heparin
were injected into the inferior vena cava, and an arterial
cannula was inserted in the superior mesenteric artery and
advanced across the aorta into the right renal artery. The right
kidney with intact ureter was removed en masse and placed in a
perfusion cabinet at a constant temperature of 37°C. The kidney
was allowed 20 mm of equilibration before the first collection
period was begun. During this period, the perinephric fat was
trimmed away and the renal vein was opened. The perfusate
volume averaged 100 cc and was recirculated continuously with
pulsatile flow using two limited pumps (Model MHRE-200,
Watson-Marlow Falmouth, Cornwall, England) with a pressure
of 130/100 mm Hg distal to the tip of the arterial cannula. The
rate of renal perfusion was begun at 40 cc/mm and was
measured continuously with a flow meter (Brooks, Emerson
Electric Co., Hatfield, Pennsylvania) inserted into the arterial
line. The perfusion media was initially prepared as a 10%
solution of albumin (bovine albumin, fraction V, Miles Labora-
tories, Elkhart, Indiana) and diluted to a final albumin concen-
tration of 6.7% and contained in millimoles: sodium 140,
potassium 5.0, chloride 115, bicarbonate 25, calcium 2.5, phos-
phate 1.2, magnesium 1.2, glucose 5, creatinine 13, and alanine
2.5. The medium was gassed with 95% 02 and 5% CO2 with a
resultant pH of 7.38. To correct for insensible losses secondary
to evaporation during the experiment, demineralized water was
added to the medium via a pump at a variable rate to maintain
constant albumin and electrolyte concentrations. This was
monitored by a refractometer (American Optical, Buffalo, New
York) every 20 mm. The GFR was determined by the clearance
of 3H-methoxy-inulin.
Following a 20-mm equilibration period, four 20-mm urine
collections were obtained. A sample of perfusate was taken
midway between each urine collection. Sodium and potassium
concentrations of the perfusate and urine were determined in
duplicate by flame-spectrophotometry (Model 143, Instrumen-
tation Laboratory, Lexington, Massachusetts). In ten non-
injured kidneys from control animals a stable and reproducible
C1, (400 20 d/min), urine flow rate (30 I p1/mm) and FENa
(2.0 0.5%) have been obtained for 90 to 120 mm using this
preparation.
(6) To assess the effect of T4 on cellular morphology following
a toxic renal insult, horseradish peroxidase was infused, intra-
venously, 24 hr after treatment with either normal saline (N =
4) of 12 ig/l00 g body weight, T4 (N = 4). Horseradish
peroxidase (40,000 daltons; Sigma Chemical Co., St. Louis,
Missouri) dissolved in mammalian ringer's (3 mg/mI) was in-
fused intravenously over a 5-mm period to deliver I ml of
solution per 100 g body weight [9]. After 5 mm, the kidneys
were fixed with retrograde perfusion with a modified Kar-
novsky's fixative containing 4% paraformaldehyde, 5% glutar-
aldehyde diluted in a one to three ratio with 0.1 M sucrose and
3% dextran 1-40. Kidneys were removed and a sagittal section
Control groups Experimental groups
Injury Saline" Saline" Dichromateh Dichromateb
Treatment Saline" Thyroxin° Saline" Thyroxin°
Numberof animals 10 10 12 13
Serum thyroxin, gId1 4.9 0.4 4.8 0.7 4.4 0.2 4.7 0.2
C,,, pilmin/100 g body wI 1070 40 1032 31 422 27° 669 36°
FENa% 0.17 0.04 0.15 0.03 l.02 0.12° 0.49 0.05°f
Uosm, mOsm/kg 1620 92 1466 80 613 23° 835 50°
° All values are mean 5EM.
Dichromate, 15 mglkg, s.c.
° Thyroxin, 4 g/l00 g body wt, i.p.
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was immersed in fixative for 1 hr at 4°C. Blocks of tissue were
then embedded in 7% agar and chopped into 4-tx thick sections
using a tissue chopper (Smith-Farquar Type, Sorvall Instru-
ments, Newtown, Connecticut). The chopped tissue samples
were washed repeatedly with 0.1 M sodium cacodylate buffer
containing 0.1 M sucrose followed by repeated washing in 0.05
Tris-hydrochloric acid buffer pH 7.5. The tissue samples were
then placed in substrate containing 5 mg of 3, 3 diaminobenzi-
dein tetrahydrochloride in 10 ml of 0.05 Tris buffer with 0.01%
hydrogen peroxide. After repeated washings in buffer solution
the tissue samples were postfixed with s-Collidine buffered
1.33% osmium tetroxide, washed in 0.1 M s-Collidine buffer,
washed in graded ethanols, and embedded in Epon. Semithin
and ultrathin sections were obtained on an ultratome III (LKB
Biochem Ltd, Cambridge, England). Unstained ultra-thin sec-
tions were examined using an electron microscope (Zeiss EM lOB
Oberkuchen, Federal Republic of Germany). Specimens were
coded and then processed and examined without knowledge of
type of injury or treatment. The degree of injury was evaluated
in electron micrographs by two observers, independently and
without knowledge of type of injury or treatment group.
All values are given as the mean SEM forgroups of animals.
Where applicable, comparison of groups was made using analy-
sis of variance or Student's t test.
Results
Time-course of reduction of C,,,. To determine the time for
treatment with T4, C1,, was determined 12, 16, 24 and 48 hr after
the injection of K-dichromate. C1,, was 624 38, 400 15, 234
10, and 420 17 Ml/min/l00 g body weight at each of these
time intervals, respectively. Thus, in all subsequent studies,
treatment was administered at the height of the renal injury, 24
hr after injection of K-dichromate.
Initial effect of T4 on toxic acute renal failure (Table I).
Serum thyroxin levels were similar in each animal group
when measured 24 hr after treatment. In the saline-injected
control animals, the administration of a single dose of T4 at
twice physiologic levels had no significant effect on C1, FENa,
or Uosm. The dichromate-injected saline-treated rats had typi-
cal features of toxic acute renal injury with C,,, reduced to 422
27 cl/min/l00 g body weight, FENa elevated to 1.02 0.12%
and U0sm diminished to 613 23 mOsm/kg as compared to
control animals with C,,, of 1070 40, FENa of 0.17 0.04, and
Uosm of 1620 92 (P <0.01 for each variable). The dichromate-
injected animals which had been treated with T4 demonstrated
better recovery of C1, 669 36; improved FENa, 0.49 0.05;
and increased U0,,,, 835 50 as compared to the dichromate-
injected saline-treated rats (P < 0.01 for each variable).
Various doses of T4 (Fig. 1). Experimental animals which
received noT4 had a C,,, of 418 25 pJ/min/lQ0 g body weight.
The degree of recovery of C1,, was directly related to the
quantity of T4 administered. Treatment with 2,4, or 12 g/l00 g
body weight of 14 resulted in C1,, of 551 38, 669 36 and 742
23 d/min/l00 g body weight, respectively. Each value of C,,,
is statistically, significantly different (P < 0.05) from the imme-
diately preceeding value.
Sustained effect of T4 (Fig. 2). Two days after the dichromate
injury, animals which had received saline had a C1,, of 422 27
xlImin/l00 g body weight, while those rats which received T4
had C1,, of 746 27 (P < 0.01). This initial beneficial effect of T4
was sustained. When studied 4 days after the toxic injury, rats
given saline had C1 of 692 38 whereas animals treated with
T4 had C1,, of 930 34 (P < 0.01), Moreover, animals treated
with 14 had nearly full recovery of C1,, by 4 days, while saline-
treated rats still had significantly reduced C1,,.
Isolated perfused kidney studies (Fig. 3). During in vitro
perfusion, kidneys obtained from dichromate-injected saline-
treated rats had markedly reduced urine flow rate (3.0 1.0
d1min), diminished C,,, (3.0 3.0 p1/mm), and elevated FENa
(85 5%) representing a severe degree of renal injury. In
contrast, the kidneys from animals which had been injected
with dichromate, but treated with T4, had significantly (P <
0.01) better urine flow rate (10 1.0 x1/min), increased C,,, (30
5 p1/mm), and better FENa (25 5%) reflecting an enhanced
recovery from the renal insult.
Morphologic' studies (Fig. 4). Examination of the kidneys of
saline-injected control animals which received thyroxin re-
vealed no qualitative morphologic differences when compared
with untreated control rats. In kidneys from dichromate-inject-
ed saline-treated rats, there was patchy necrosis of the epitheli-
um of the 5, and S2 segments of the proximal tubule. Involve-
ment of the S1 segment was not as prominent. These changes in
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Fig. 2. Dichromate-induced acute rena/failure. Treatment with thyrox-
in produces an initial improvement in inulin clearance (2 days) which is
sustained (4 days). The thyroxin-treated animals have nearly full
recovery of C1, by 4 days after the injury.
Fig. 1. A dose-response relationship in animals with dichromate-
induced toxic acute renal failure and treatment with varying doses of
thyroxin at the height of the renal injury. Inulin clearance (C,,,) was
determined 24 hr after treatment.
2 Days 4 Days
Time after dichromate injection
E
25
0
Dichromate
Saline
Fig. 3. Dichromaie-induced acute renal failure in isolated perfused
kidney. Kidneys taken from animals with dichromated-induced toxic
acute renal failure have improved inulin clearance (C1,,) during isolated
perfusion when treated with thyroxin.
the proximal tubule included varying degrees of mitochondrial
condensation or swelling, dilatation of the smooth endoplasmic
reticulum, loss of the brush border with the formation of blebs
and accumulation of numerous small vacuoles within the cyto-
plasm, (Fig. 4A). In cells in which there was frank necrosis, the
cytologic architecture could no longer be distinguished and only
fragments of cell membrane and organelles could be seen. In the
distal nephron, frank necrosis was not observed, but there was
evidence of increased permeability to the tracer horseradish
peroxidase. The cytoplasm of individual cells demonstrated the
presence of reaction product in cortical and outer medullary
collecting ducts.
In animals injected with dichromate and treated with thyrox-
in, there was a striking preservation of the cellular architecture
when compared to those who received dichromate alone.
Although there was evidence of dilatation of the intercellular
spaces and mitochondrial condensation, foci of necrosis were
less common and usually occurred in a piecemeal fashion in
single cells with the neighboring cells being well preserved. The
degree of cytologic change was also less severe and areas of
denuded basement membrane were not evident (Fig. 4B).
Discussion
Over the past 30 years, the pathophysiology of acute renal
failure has been investigated extensively in experimental ani-
mals and humans [17, 181. Initially, attention was attracted to
the intense vasoconstriction of the renal cortex which occurs in
acute renal failure induced by norepinephrine, renal artery
clamping, and some toxins [18, 201 and which has been docu-
mented in patients [21]. Although early evidence suggested that
the renin-angiotensin system was the primary effector of this
response [22, 23], recent studies would suggest that other
mediators such as adenosine should be considered. The back-
leak of tubular fluid and intratubular obstruction has been
evaluated in several types of acute renal failure because of the
observation that inulin clearance obtained from superficial
single nephrons is consistently greater than whole kidney inulin
Fig. 4. Cross sections of S2 segments of proximal tubule. A Electron
micrograph of a cross section of an S2 segment of the proximal tubule
from a dichromate-injected saline-treated animal. There is focal necro-
sis with denudation of the basement membrane. The remaining tubular
cells are swollen and contain numerous apical vesicles. (x1630) B
Electron micrograph of a cross section of an S2 segment of the
proximal tubule from a dichromate-injected thyroxin-treated animal.
No necrosis is seen. There is dilation of the intercellular spaces,
increased numbers of lysosomes, and some apical vacuolization. The
brush border is relatively intact. (x 1630)
clearance during both the maintenance and recovery phases of
experimental acute renal failure [8, 24, 25]. In fact, Myers et al
[26] have documented a backleak of glomerular filtrate in
patients with acute renal failure. Venkatachalem et al [271 have
provided elegant morphologic confirmation of loss of tubular
permeability and demonstrated tubules impacted with mem-
brane blebs and debris.
When administered prior to the renal injury, a number of
agents will attenuate the severity of an acute renal insult and
modify the loss of renal function [18]. A series of studies from
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Fig. 5. A comparison of the beneficial jTeci qf ihyroxin (12 pgIlOo
gibody WI) and ATP-MgCI2 (50 j.t moles) in animals wit/i dichromate-
induced toxic acute rena/failure. The degree of recovery of C1 is quite
similar in both groups of animals 2 days after the injury as compared to
the saline-treated control group.
our laboratory have shown that the administration of adenine
nucleotides combined with magnesium chloride, after the in-
duction ofan ischemic [8, 9], toxic [10], or obstructive [11] renal
injury, will result in enhanced recovery of renal function and
the preservation of sublethally injured tubular epithelial cells.
The present study was based on these observations and the
findings of Schulte-Wissermann, Straub, and Funke [1,21 who
demonstrated that treatment with thyroxin would result in
accelerated recovery of enzyme activity in renal cortex of
animals which had been given mercuric chloride. These investi-
gators hypothesized that thyroxin could provide a source of
metabolic energy for the stimulation of gluconeogenesis and
eventual repair of the tubular epithelium [I, 21. It is of consider-
able interest, in this regard, that the degree of enhanced
recovery of C1,, obtained in the thyroxin-treated rats is quite
similar to that found in animals given ATP-MgCI2 (Fig. 5).
In the present study we have demonstrated that treatment
with thyroxin at the height of a toxic renal injury will: (1)
accelerate the recovery of glomerular and tubular function, (2)
result in nearly complete recovery of C. within 4 days of the
initial injury while untreated animals require a more prolonged
period to return to control values [281, (3) produce significant
improvement in tubular morphology, and (4) remain effective
even when the kidneys are studied during in vitro perfusion.
Thyroid hormone is known to have a number of systemic,
renotropic, and hemodynamic effects including a nonspecific
enhancement of GFR [29]. It seems unlikely that the beneficial
effect of thyroxin in the present study can be attributed solely to
these systemic effects. These renotropic and hemody-
namic effects have been described in animals with hyperthy-
roidism following the long-term administration of thyroid hor-
mones and associated with elevated serum levels of T3 or T4
[29, 30]. In the present study only a single dose of the hormone
was given, a state of sustained hyperthyroidism was not in-
duced and serum levels of T4 were similar in all groups of
animals when measured 24 hr after treatment. Although the
chronic administration of T1 has been shown to increase C1 and
decrease FENa [301, such effects were not seen in the saline-
injected control rats which received only a single dose of T4, but
salutary effects were demonstrated in dichromate-injected ani-
mals. In addition, studies using the isolated perfused kidney
would have eliminated any residual influences of T4 on renal
hemodynamics which may have been present at the time that
renal function studies had been done. We cannot eliminate the
possibility of a transient increase in cardiac output or renal
perfusion in the T4-treated animals, but such changes would
have had to induce sustained improvement in the dichromate-
injected animals while having no effect on control rats. Lastly,
we would not expect such dramatic improvement in the histo-
morphometric features of the epithelial cell if the improved
function was due only to transient or residual systemic or
hemodynamic effects.
Although the conversion of T4 to T3 is known to be reduced
with renal insufficiency, the present study was carried out using
T4 because this was the form of the hormone used by Schulte-
Wissermann, Straub, and Funke [1, 2] whose previous studies
formed the basis for this investigation. Moreover, a beneficial
effect was seen in the T4-treated animals and, thus, diminished
conversion of T4 toT3 would serve only to reduce the impact of
T4 on recovery of renal function and would have diminished,
not enhanced, the results we obtained. Our finding that the
serum level of total T4 was similar in all animal groups must be
interpreted with caution because this value was measured at
only one point in time (that is, 24 hr after the administration of
T4). Thus, a transient increase in serum T4 values during the
period after treatment may have occurred. More detailed stud-
ies of the kinetics of intraperitoneal administration of T4 in the
rat would be required to address this issue. However, the
finding of a beneficial effect of T4 on the recovery of renal
function without a sustained elevation in serum T4 levels is
important because it documents that the treatment with T4 did
not simply replace thyroid function which had been ablated by
the injection of K-dichromate and because it indicates that a
state of sustained hyperthroidism does not have to be induced
to obtain a beneficial effect on renal function.
The precise cellular mechanisms responsible for the benefi-
cial effect of thyroxin cannot be determined from the present
study. However, this hormone has been shown to stimulate
gluconeogenesis [291 and Na-K ATPase activity in the renal
cortex [3—5, 30]. In fact, this hormone can influence protein
synthesis in the renal cortex so as to account for an increase in
both the number and activity of Na-K ATPase units [3—5] and to
promote glucose and amino acid uptake [6, 7] by epithelial cells.
Each of these effects would be expected to aid the repair and
regeneration of injured tubular epithelial cells. It is tempting to
speculate that thyroxin and the adenine nucleotides may share a
common molecular mechanism, such as repletion of cellular
nucleotides, or repair of cell membranes by restoration of Na-K
ATPase pumps. Both of these effects would augment cell
volume regulation and enhance recovery from an acute renal
injury.
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